Literature DB >> 7207217

Sex hormone status of the postmenopausal woman.

A Vermeulen.   

Abstract

Plasma levels of testosterone, androstenedione, dehydroepiandrosterone and its sulphate, and of androstenediol, as well as estrone and estradiol, were determined in several groups of postmenopausal women. The ovaries contribute to plasma estrogen levels only early in the postmenopause, but continue to secrete testosterone and minimal amounts of androstenedione throughout the postmenopause. With age there is a decreased secretion by the adrenal of dehydroepiandrosterone (sulphate) and of androstenediol. The levels of androstenedione and estrone and the androstenedione/estrone ratio remain unchanged with increasing age. The levels of estrone and estradiol, and the ratios, estrone/androstenedione and estradiol/testosterone, are correlated with fat mass. There is also an inverse curvilinear relationship with precursor concentration. This suggests either a progressive saturation of the tissular aromatase with increasing percursor level, or the existence of an unknown estrogen precursor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7207217     DOI: 10.1016/0378-5122(80)90040-7

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  3 in total

1.  Endocrine profile in breast cancer patients receiving chemotherapy.

Authors:  R R Mehta; C W Beattie; T K Das Gupta
Journal:  Breast Cancer Res Treat       Date:  1992-01       Impact factor: 4.872

Review 2.  Pelvic radiotherapy, sex hormones, and breast cancer.

Authors:  P D Inskip
Journal:  Cancer Causes Control       Date:  1994-09       Impact factor: 2.506

3.  Dehydroepiandrosterone Sulfate Stimulates Expression of Blood-Testis-Barrier Proteins Claudin-3 and -5 and Tight Junction Formation via a Gnα11-Coupled Receptor in Sertoli Cells.

Authors:  Dimitrios Papadopoulos; Raimund Dietze; Mazen Shihan; Ulrike Kirch; Georgios Scheiner-Bobis
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.